Highly mobile, invasive ovarian cancer cells called ‘leader cells’ have been identified as leading the attack on healthy tissue.
Dr Maree Bilandzic explains this pivotal discovery, published in Cancers, and the significance of leader cells in finding more effective therapies for ovarian cancer.
Collaborators | Monash University, Bruker Biosciences Pty Ltd, Monash Health, RMIT University
Funders | Contributing to Australian Scholarship in Science (CASS) foundation, Ovarian Cancer Research Foundation, Victorian Government’s Operational Infrastructure Support Program
Hudson Institute communications
t: + 61 3 8572 2697